Cite
HARVARD Citation
Dutzer, D. et al. (2018). Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients. Alimentary pharmacology & therapeutics. 47 (11), pp. 1571-1573. [Online].